Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
54,965,124
-
Total 13F shares
-
14,068,910
-
Share change
-
-306,816
-
Total reported value
-
$134,634,338
-
Put/Call ratio
-
2.1%
-
Price per share
-
$9.57
-
Number of holders
-
71
-
Value change
-
-$3,382,215
-
Number of buys
-
38
-
Number of sells
-
23
Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q4 2022
As of 31 Dec 2022,
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,068,910 shares.
The largest 10 holders included
Hudson Executive Capital LP, Blue Water Life Science Advisors, LP, Polar Capital Holdings Plc, BlackRock Inc., VANGUARD GROUP INC, Board of Trustees of The Leland Stanford Junior University, Granahan Investment Management, LLC, SVB WEALTH LLC, RTW INVESTMENTS, LP, and Uniplan Investment Counsel, Inc..
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.